CompaniesProJenX
ProJenX logo

ProJenX

active
New York, NY, United States
Founded 2021
Website
About

Brain-penetrant therapies to address debilitating brain diseases

Areas of Focus

Categories

Small Molecule PharmaceuticalNJ, NY, PA
Clinical Trials (1)
View all

Total Trials

1

As Lead Sponsor

1

As Collaborator

0

Total Enrollment

72

By Phase

PHASE1: 1

By Status

RECRUITING: 1
Clinical Trials Pipeline1 trial
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2021
2022
2023
2024
2025
2026
2027
Today
NCT05279755
Hover over trial bars to see details

Recent Trials

NCT05279755Lead Sponsor
A Study to Evaluate the Safety and Pharmacokinetics of Single and Multiple Doses of Prosetin in Healthy Volunteers and Participants With ALS
PHASE1Recruiting
72 participants
Started: Feb 26, 2022 · Completed: Oct 31, 2026
Funding History (1)
D
Jan 21, 2022
Filing
Locations (1)
Headquarters
New York, NY, United States
Map

Loading map...